Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-masked, Randomized, Vehicle-controlled Study Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease

NCT07264517 is registered in ClinicalTrials.gov with Instituto Grifols, S.A. as lead sponsor.

NCT NCT07264517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07264517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-masked, Randomized, Vehicle-controlled Study Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease
Lead sponsor
Instituto Grifols, S.A.
Phase
Phase 2
Overall status
Completed
Start date
November 3, 2025
Completion date
May 20, 2026
Enrollment
103 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease